40 results
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
3 Jan 24
Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary
7:00am
potential in PSC and other fibro-inflammatory disorders. CM-101 has Orphan Drug designation for PSC in the U.S. and the European Union (EU
F-3
EX-1.2
CMMB
Chemomab Therapeutics Ltd
16 Oct 23
Shelf registration (foreign)
4:25pm
of Treasury’s Office of Foreign Assets Control (“OFAC”), the United Nations Security Council, the European Union, His Majesty’s Treasury, or other relevant … , CCPA, and the European Union General Data Protection Regulation (“GDPR”) (EU 2016/679) (collectively, the “Privacy Laws”). To ensure compliance
8-K/A
rvj 9tg9kyrxnxqwo
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am
8-K
EX-10.1
jqh6b6 t13h
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
424B3
n2k72fs0h57ow
12 Feb 21
Prospectus supplement
12:05pm
S-4/A
14s12vb2
10 Feb 21
Registration of securities issued in business combination transactions (amended)
1:19pm
S-4
lzqdfal3
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-2.1
lhbljvyirzzrlr
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.1
dzj2d
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.7
babw fy368sx
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
8-K
EX-2.1
7n4 r3eb5
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-2.1
wpnzziyt5
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEF 14A
vc2w xprk30e83tuzl2
6 Apr 20
Definitive proxy
6:11am
PRE 14A
gm7m7
30 Mar 20
Preliminary proxy
5:03pm
10-K
qe6xxrzaw2jfgo1hb0e5
17 Mar 20
Annual report
5:27pm